CMO Dawn Keller explains why a social-first approach is required for a brand that doesn’t have a massive advertising budget.
After a successful launch in 2024, Sprite Chill will become a permanent addition to the Coca-Cola brand’s portfolio, according to details shared with Marketing Dive. Debuting last April, the soft ...
The US regulator has cleared the combination of muscarinic M1 and M4 agonist xanomeline tartrate and muscarinic antagonist trospium chloride ... under the Cobenfy brand name for the treatment ...
In brand strategy, “brand personality” refers to a unique blend of human characteristics associated with a brand. These traits shape how people perceive and interact with the brand, whether seen as ...
Forbes contributors publish independent expert analyses and insights. Quentin Singer is music journalist who covers rock and heavy music.
Royal fans, rejoice — Meghan Markle is gearing up to release her new lifestyle brand! The Duchess of Sussex, 43, announced on February 17, 2025, that she had changed the name of the brand from ...
A brand new biotech – Neurosterix – has been ... this year on its schizophrenia candidate KarXT (xanomeline tartrate/trospium chloride), which combines an M4 antagonist with an M1 agonist ...
Physical, tangible brand experiences—a well-placed billboard, an unexpected direct mail piece or a cleverly designed giveaway—can leave a lasting impression that digital ads simply can’t ...
Meghan Markle is owning it. The Duchess of Sussex, 43, admitted that she made “mistakes” in the launch of her As Ever brand in a rare interview with People published Monday. “I appreciate ...
Now, in her post-royal era, Meghan Markle has As Ever, another lifestyle brand with a new name, which she says is sort of an extension of the blog. As Ever, previously called American Riviera ...
18 天
Zacks Investment Research on MSNEC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCCBristol Myers BMY announced that the European Commission (EC) has approved the blockbuster immuno-oncology drug Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果